Company intelligence / Profile preview

Eye Physics

Los Alamitos, California, United States

Ownership: Private
Development stage: Other

Overview

Eye Physics is a specialized medical technology company focused on advanced ophthalmic plaque brachytherapy for the treatment of ocular tumors, such as uveal melanoma. The company provides custom-designed radioactive plaques and the proprietary Plaque Simulator treatment planning software, which allows for highly precise 3D radiation dose distribution. Their technology is designed to optimize tumor coverage while minimizing radiation exposure to critical healthy eye structures like the optic nerve and macula. Eye Physics products are widely utilized in major ocular oncology centers to improve patient outcomes and vision preservation through personalized dosimetry.

Therapeutic areas: Oncology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

University of Southern California Roski Eye Institute

Beyond the preview

Go deeper on Eye Physics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eye Physics.

Explore the full profile